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subunit ND1with high speciﬁcity. The photocross-linkingwas completely blocked in the presence of just a 5-fold
excess of bullatacin, indicating that [125I]DANA is an excellent mimic of natural acetogenins and hence binds to
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The proton-pumpingNADH-ubiquinone oxidoreductase (complex I)
catalyzes the oxidation of NADH by ubiquinone, coupled to the
generation of an electrochemical proton gradient across the membrane
that drives energy-consuming processes such as ATP synthesis and
ﬂagella movement [1–3]. Complex I is the largest multisubunit enzyme
in the respiratory chain. The enzyme from bovine heart mitochondria
is composed of 45 different subunits with a combined mass of about
1 MDa [4]. The prokaryotic enzyme is simpler, consisting of 14 core
subunits conserved frombacteria to humans. The crystal structure of the
hydrophilic domain (peripheral arm) of complex I from Thermus
thermophilus was solved at a resolution of 3.3 Å, revealing the subunitarrangement and the putative electron transfer pathway [5]. Recently,
the structure of entire complex I from T. thermophilus [6] and Yarrowia
lipolytica [7] was solved at 4.5 and 6.3 Å, respectively. As expected from
electron microscopic studies [8,9], the enzyme is L-shaped with a
membrane domain and a hydrophilic domain. However, information
about contact between the two domains, thought to be critical for the
function of the enzyme and form a large binding pocket for quinone/
inhibitor [10,11], is still highly limited because the loop regions of the
membrane domain were not resolved [6].
Investigating the actionmechanism of various inhibitors of complex I
is invaluable for obtaining insights into the functional and structural
features of the enzyme [12–14]. We have performed photoafﬁnity
labeling studies to identify the binding sites of different inhibitors of
bovine heart mitochondrial complex I. For instance, we showed that a
photoreactive acetogenin mimic ([125I]TDA), which has a photoreactive
aryldiazirine group at the position corresponding to the γ-lactone ring of
natural acetogenins, binds to the region spanning the fourth to ﬁfth
transmembranehelices (Val144–Glu192) in theND1 subunit [15,16].We
also revealed that a quinazoline-type inhibitor binds to the interfacial
region of the ND1 and 49 kDa subunits and that the photocross-linked
residue in the 49 kDa subunit is located within the N-terminal region,
Asp41–Arg63 [17]. These ﬁndings strongly suggest that the ND1 and
49 kDa subunits are in contact with each other and that the arylazido
group of [125I]AzQ is located between them, consistent with the crystal
structure of the entire complex I from T. thermophilus [6]. Although the
large cytoplasmic loops of the Nqo8 subunit (ND1 in bovine) were not
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of contact with the ND1 subunit. On the other hand, mutagenesis studies
using the yeast Yarrowia lipolytica [18–20] and Rhodobacter capsulatus
[21] indicated that the PSST and 49 kDa subunits contribute to the
inhibitor binding domain. Taken together, it is most likely that the PSST,
49 kDa, and ND1 subunits construct the inhibitor/quinone binding
pocket in complex I.
Δlac-acetogenins synthesized in our laboratory such as compound
2 (Fig. 1) are a new type of inhibitor of bovine complex I. Their
inhibitory effects differ in several points from those of classical
inhibitors such as rotenone, piericidin A and natural acetogenins
[15,22–24]. For instance, Δlac-acetogenins generate much less
superoxide than do classical inhibitors [23,24]. Recently, on the
basis of photoafﬁnity labeling using a photoreactive mimic of Δlac-
acetogenins ([125I]DAA, Fig. 1), we indicated that the hydroxylated
bis-THF ring moiety binds at two different sites, site A in the Ala135–
Phe198 region and site B in the Asp199–Lys262 region, in the third
matrix-side loop connecting the ﬁfth and sixth transmembrane
helices in the ND1 subunit [25]. Taking into consideration the results
of competition tests conducted under various experimental condi-
tions, we proposed that site A and site B are sites that accommodate
the bis-THF motif of natural acetogenins and Δlac-acetogenins,
respectively [25]. As insights into the functional and structural
features of the matrix-side loop regions of the ND1 subunit are
critical to elucidating the dynamic interaction between the hydro-
philic and membrane arms, deepening knowledge about the inhibitor
binding site(s) resided in the regions is requisite. In this sense, the
above proposition needs to be directly veriﬁed using a natural
acetogenin-type photoreactive probe, since [125I]DAA has no γ-lactone
ring, which is a common structural component for natural acetogenins.
We here conducted photoafﬁnity labeling with bovine submito-
chondrial particles (SMP) using a newly synthesized natural acet-
ogenin mimic ([125I]diazinylated natural acetogenin, [125I]DANA,
Fig. 1), which has a small photoreactive diazirine group, in place of
a hydroxy group, attached to the bis-THF moiety. Our results revealed
that the residue(s) cross-linked by [125I]DANA is located at the
proposed site A in the ND1 subunit.
2. Materials and methods
2.1. Materials
Bullatacin and piericidin A were kindly provided by Drs. J. L.
McLaughlin (Purdue University, West Lafayette, IN) and S. Yoshida
(The Institute of Physical and Chemical Research, Saitama, Japan),
respectively. The rabbit anti-ND1 antibody was a generous gift fromFig. 1. Structure of test compoundDr. T. Yagi (The Scripps Research Institute, La Jolla, CA). The Δlac-
acetogenin (2) and deoxy acetogenins (3 and 4) were the same
samples used previously [23,26]. Protein standards (Precision Plus
Protein standards and Kaleidoscope Polypeptide Standards) for SDS-
PAGE were purchased from Bio-Rad (Hercules, CA). [125I]NaI was
purchased from Perkin Elmer (Waltham,MA). Other reagents were all
of analytical grade.
2.2. Synthesis of DANA and [125I]DANA
The synthetic procedures of DANA and its 125I-labeled derivative
([125I]DANA) were described in Ref. [27]. The speciﬁc radioactivity
was ~2000 Ci/mmol, and radiochemical purity was determined to be
over 99%.
2.3. Preparation of bovine submitochondrial particles and enzyme assays
Bovine heart submitochondrial particles (SMP) were prepared by
the method of Matsuno-Yagi and Hateﬁ [28] and stored in a buffer
containing 250 mM sucrose and 10 mM Tris/HCl (pH 7.4) at −80 °C
until use. The NADH oxidase activity in SMP was measured according
to the procedures described previously [25].
2.4. Photoafﬁnity labeling of SMP
Bovine SMP (0.6–1.0 mg of protein/mL, 100 μL in a 1.5 mL tube)
were incubated with [125I]DANA (6–15 nM) in buffer containing
250 mM sucrose, 1 mM MgCl2 and 50 mM KPi (pH 7.4) for 10 min at
room temperature. The samples were photoirradiated for 15 minwith
a long wavelength UV lamp (Black Ray model B-100A, UVP, Upland,
CA) on ice at a distance of 10 cm from the light source [15]. When
competitionwas examined, a competitor was added and incubated for
10 min with [125I]DANA prior to the photoirradiation.
2.5. Electrophoresis
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) was performed according to Laemmli [29]. Brieﬂy, photoafﬁnity-
labeled samples were added to 4× Laemmle's sample buffer and
incubated at 35 °C for 1 h to avoid protein aggregation. These
denatured samples were separated on 12.5% Laemmli's gels. After
the electrophoresis, the gels were stained with CBB R-250, dried and
exposed to an imaging plate (BAS-MS2040, Fuji Film, Tokyo, Japan).
The migration patterns of radiolabeled proteins were analyzed and
visualized with a Bio-Imaging Analyzer FLA-5100 (Fuji Film). The
radioactivity of each band was quantiﬁed from the digitalized datas used in the present study.
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slices using a γ-counting system (COBLA II, Packard).
Analytical Blue Native (BN)-PAGE (analytical scale) was per-
formed using the Native PAGE Novex Bis–Tris Gel System with a 4–
16% pre-cast gel (Invitrogen, Carlsbad, CA). The SMP photocross-
linked by [125I]DANA were solubilized with 1% (w/v) DDM for 1 h on
ice, and mixed with 4× sample buffer and 5% (w/v) Serva blue G (CBB
G-250). Electrophoresis was performed at a voltage of 150 V with a
limited current of 15 mA/gel in a cold room. After the electrophoresis,
the complex I band was identiﬁed by staining “in-gel” activity with
the NADH/NBT system [30] and autoradiographed as described above.
Preparative BN-PAGE was performed using a 6% isocratic hand-
cast gel (160×180×2 mm) [31]. Complex I was isolated by electro-
elution in an elution buffer containing 25 mM tricine and 7.5 mM
Bistris (adjusted to pH 7.0 with HCl) using a Centrilutor equipped
with a Centricon YM-100 (Millipore, Billerica, MA). The complex I
obtained was stored at −80 °C until used.2.6. Immunochemical analysis
Immunoprecipitation of the ND1 subunit was carried out accord-
ing to procedures described previously using the electroeluted
complex I as a starting material [15,25]. The electroeluted complex I
was denatured with 1.25% SDS (60 μL), and diluted with binding
buffer (240 μL) containing 1.25% Triton X-100, 190 mM NaCl, 6 mM
EDTA, 0.1 mM PMSF and 60 mM Tris/HCl (pH 7.4). The rabbit anti-
bovine ND1 antiserum (5 μL) was added to the mixture (300 μL) and
incubated overnight in a cold room. Protein A-sepharose 4 (30 μL
surly, equilibrated with the binding buffer, GE healthcare, UK) was
added and rotated for 2 h at room temperature. The suspension was
washed 4 times (0.8 mL) with a washing buffer containing 0.1% Triton
X-100, 0.02% SDS, 150 mMNaCl, 5 mM EDTA and 50 mM Tris/HCl (pH
7.4), and once (0.8 mL) with a washing buffer without detergents. The
captured ND1 on the resin was released by treatingwith 1× Laemmli's
buffer and subjected to SDS-PAGE and autoradiography.2.7. Isolation and limited proteolysis of the ND1 subunit
For limited proteolysis of the ND1 subunit, the SMP cross-linked by
[125I]DANAwere partially isolated by SDS-PAGE on a 12.5% Laemmli's gel
as described previously procedure [16]. Limited proteolysis was
performed using lysylendopeptidase (Lys-C, Wako Pure Chemicals,
Osaka, Japan), endoprotease Asp-N (Roche Applied Science, Penzberg,
Germany), or trypsin (Promega, Madison, WI) in 50 mM Tris/HCl buffer
(pH 8.5, containing 0.1% SDS), 50 mM phosphate buffer (pH 8.5,
containing 0.01% SDS), or ammonium bicarbonate buffer (pH 7.8,
containing 0.01% SDS), respectively [16,25]. The digestionwas continued
overnight at 35 °C. The digestion was quenched with 4× sample buffer
and the samplewas further analyzed by tricine/SDS-PAGE (16.5% T/6% C)
[32].
For digestion of the ND1 subunit by a combination of two proteases,
Asp-N/trypsin (ﬁrst/second proteases), Lys-C/trypsin, Asp-N/Lys-C, or
Lys-C/Asp-N was used under the experimental conditions described
above. The peptide digested by the ﬁrst protease was electroeluted and
consequently exposed to the second protease.Fig. 2. Photoafﬁnity labeling of bovine SMP by [125I]DANA. Bovine SMP (0.6 mg of
protein/mL) were photocross-linked by 6 nM [125I]DANA, and analyzed by SDS-PAGE
on a 12.5% Laemmle's gel (24 μg and 12 μg of protein/lane for CBB (left) and
autoradiography (right), respectively.2.8. Sequence analysis and topology prediction of the ND1 subunit
The number of transmembrane helices and membrane topology of
the bovine ND1 subunit were predicted as described previously [25].
The mobility shifts of enzymatic digests on tricine gel were compared
with theoretical digests of the published protein sequences of the
bovine ND1 (Swiss Prot: P03887) using Peptide Mass (http://expasy.
org/tools/peptide-mass.html).3. Results
3.1. Design synthesis and characterization of the inhibitory effect of DANA
Structure–activity studies of numerous natural and synthetic
acetogenins demonstrated that a lack of both hydroxy groups adjacent
to the bis-THF ring results in a drastic decrease in the inhibitory activity,
but thepresenceof either group sufﬁciently sustains strongactivity at the
nM level [26]. For instance, the IC50 values of the deoxy derivatives 3 and
4 (Fig. 1) with the NADH oxidase activity in SMP (30 μg of protein/mL)
were 3.1 (±0.40) and 2.7 (±0.35)nM, respectively. Therefore, to
identify the binding site of the hydroxylated bis-THF ring of natural
acetogenins,we synthesized [125I]DANAwhichhas a small photoreactive
diazirine group, in place of a hydroxy group, attached to the bis-THF
moiety [27]. The IC50 values of DANA and bullatacin were 1.1 (±0.20)
and 0.90 (±0.11)nM, respectively, indicating that DANA retains strong
inhibitory activity irrespective of displacement of the hydroxy group
with a diazirine group.
3.2. Photoafﬁnity labeling of bovine SMP using [125I]DANA
For the photoafﬁnity labeling experiment, SMP were used to
ensure the intactness of complex I. When SMP (0.6 mg of protein/mL)
were UV-irradiated in the presence of 6 nM [125I]DANA, only one
cross-linked protein, with an apparent molecular mass of approxi-
mately 30 kDa, was found on the SDS-gel (Fig. 2). By subjecting the
photocross-linked complex I, which was isolated by electroelution
after Blue Native PAGE, to immnoprecipitation with the bovine ND1
antibody, it was clearly revealed that the radiolabeled protein is the
ND1 subunit in the membrane arm of complex I [27].
3.3. Suppression of the speciﬁc labeling of ND1 by other complex I inhibitors
We examined the effect of various complex I inhibitors on the
speciﬁc cross-linking of theND1 subunit by [125I]DANA. It is noteworthy
that just a 5-fold excess of bullatacin almost completely suppressed the
cross-linking (Fig. 3). This suppression is the most pronounced effect
among the photoafﬁnity labeling studies performed in our and other
laboratories [13,15–17]. This ﬁnding indicates that [125I]DANA is an
excellent mimic of natural acetogenins and hence may bind to the site
that accommodates natural products. As shown in Fig. 3, classical
inhibitors such as rotenone and piericidin A also suppressed the cross-
Fig. 3. Effect of various complex I inhibitors on the speciﬁc cross-linking of ND1 by [125I]
DANA. SMP (0.6 mg of protein/mL) were photocross-linked by 6 nM [125I]DANA in the
presence of a given concentration of complex I inhibitors. The labeled SMP were
separated on a 12.5% Laemmli's gel and the residual radioactivity in the ND1 subunit
was measured. Data are the mean for at least two independent experiments.
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radioactivity was retained in the ND1 subunit even in the presence of a
500-fold excess of Δlac-acetogenin (2). Considering the high binding
afﬁnity of 2 [24], this result indicates that the binding site of Δlac-
acetogenin fairly differs from that of classical inhibitors including
natural acetogenins, as reported previously [15,23,24].Fig. 4. Proteolytic analysis of the ND1 subunit cross-linked by [125I]DANA. The cross-linked N
methods”. (A) The isolated ND1 subunit was digested by lysylendopeptidase (Lys-C, left),
addition of 4× sample buffer and followed by tricine/SDS-PAGE (16.5% T/6% C). The amoun
representative of three independent experiments. (B) A digestion map of the ND1 subunit. A
of the ND1. The number and position of transmembrane helices of the ND1 subunit were pred
the bovine ND1 subunit (P03887).3.4. Analysis of the cross-linked region of [125I]DANA in the ND1 subunit
We characterized the binding site of [125I]DANA in the ND1
subunit by analyzing fragmentation patterns of the cross-linked ND1
generated by proteolysis using different proteases. The digestion of
the cross-linked ND1 by Lys-C gave a single radioactive band with an
apparent molecular mass of ~15 kDa on a tricine gel (Fig. 4A). Careful
analysis of the sites cleavable by Lys-C (Fig. 4B, top) revealed the
sequence Tyr127–Lys262 with a calculated molecular mass of
15.1 kDa, which covers the fourth to seventh transmembrane helices.
The digestion of the cross-linked ND1 by Asp-N gave two
radioactive digests with an apparent molecular mass of ~17 kDa and
~9 kDa at a frequency of ~3:1 (Fig. 4A). Taking into consideration the
theoretical cleavable sites by Asp-N (Fig. 4B, center) along with the
result of the Lys-C digestion, these fragments must be Asp51–Phe198
(covering the second to ﬁfth transmembrane helices, 16.3 kDa) and
Asp199–Tyr282 (covering the sixth to seventh transmembrane
helices, 9.7 kDa). These results are similar to those obtained with
[125I]DAA [25], indicating that [125I]DANA also has two different cross-
linking sites in the ND1 subunit. It is, however, realized that the
radioactivity in the ~9 kDa band relative to the ~17 kDa band was
signiﬁcantly weaker than that observed for [125I]DAA, being ~3:2 [25].
To further analyze the cross-linked region, we conducted tryptic
digestion of the cross-linked ND1 subunit. The tricine/SDS-PAGE
analysis of the tryptic digests gave three radioactive bands with an
apparent molecular mass of ~9 kDa (band 1), ~8 kDa (band 2), andD1was partially puriﬁed by SDS-PAGE and electroelution as described in “Materials and
endoprotease Asp-N (center), or trypsin (right). The digestion was quenched by the
ts of proteases added are indicated at the top of each autoradiogram. Data shown are
schematic representation of Lys-C (top), Asp-N (middle), or tryptic (bottom) digestion
icted as described previously [25]. The residue numbers refer to themature sequence of
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trypsin (Fig. 4B, bottom) along with the results of Lys-C and Asp-N
digestion, these fragments may be generated from the region covering
the fourth to seventh transmembrane helices, such as Ala135–Arg195
(6.8 kDa), Tyr127–Arg195 (7.7 kDa), Ala196–Lys262 (7.5 kDa), and
Ala196–Arg274 (9.0 kDa). In the previous study [25], we tentatively
assigned band 1 and band 2 as the fragments Ala196–Lys262 (7.5 kDa)
and Ala135–Arg195 (6.8 kDa), respectively. However we did not pay
any attention to band 3 because only a trace amount was present (see
Fig. 5 in Ref. [25]). This difference in the fragmentation pattern may be
due to a difference in the susceptibility of the ND1 subunit to trypsin
owing to the modiﬁcation by different cross-linkers, i.e. [125I]DAA vs.
[125I]DANA. Anyhow, the peptide mapping of this region attained by
tryptic digestion needs to be reinvestigated.
To clarify the fragmentation patterns, we carried out digestion of the
cross-linked ND1 with a combination of two proteases, either Asp-
N/trypsin (ﬁrst/second protease), Lys-C/trypsin, Asp-N/Lys-C, or Lys-
C/Asp-N. All treatments provided apparently oneband, identical to band
3 (Fig. 5A). Taking into account the breadth of these bands, they
probably contain multiple fragments of ~7 kDa such as Ala135–Arg195
(6.8 kDa), Ala196–Lys262 (7.5 kDa) and Tyr127–Arg195 (7.7 kDa),
which cannot be separated by tricine/SDS-PAGE. As there are many
theoretical sites cleavable by trypsin in the region of fourth to seventh
transmembrane helices, bands 1 and 2 detected in Fig. 4A may contain
longer fragments, such asAla196–Arg274 (9.0 kDa) andAla196–Arg279
(9.5 kDa). All things considered, it is reasonable to conclude that theFig. 5. Proteolytic analysis of the cross-linked ND1 subunit by combinations of two proteases
(10 pmol), being identical to that shown in Fig. 4A. The combinations of proteases are
independent experiments. (B) A schematic representation of the proteolytic analysis withfragments in band 3 cover the region from the fourth transmembrane
helix to Arg195 and from Ala196 to the seventh transmembrane helix,
and that the former contains the proposed site A, the binding site for the
bis-THF motif of natural acetogenins [25].
To pinpoint the amino acid residue(s) cross-linked by [125I]DANA,
we carried out MALDI-TOF-MS and LC-ESI-MS analyses of the tryptic
digests of ND1 subunit. However, no peptide covering the fourth to
seventh transmembrane helices was detected because of low sequence
coverage (~15%) of the subunit, as reported by several research groups
[17,33–36].
3.5. Effect of Δlac-acetogenin on the binding of [125I]DANA to the
different sites
The above results strongly suggest that the bis-THF motif of [125I]
DANA predominantly binds to site A, whereas a fraction of [125I]DANA
binds to the region covering Ala196 to the seventh transmembrane
helix. It is important to establish whether the latter is identical to the
binding site of the bis-THF motif of Δlac-acetogenin, namely the
proposed site B [25]. We examined, therefore, the residual radioac-
tivity in the two fragments generated by Asp-N (i.e. Asp51–Phe198
and Asp199–Tyr282) in the presence of Δlac-acetogenin (2).
SMP (0.6 mg of protein/mL) were cross-linked with 6 nM [125I]
DANA in the presence of 3 μM 2 (500-fold), digested by Asp-N and
subjected to a tricine/SDS-PAGE analysis. As shown in Fig. 6, the
radioactivity of the fragmentAsp199–Tyr282was just slightly (20–30%). (A) The lane marked with an asterisk shows the digestion pattern generated by trypsin
indicated at the top of each autoradiogram. Data shown are representative of three
combinations of proteases.
Fig. 6. Comparison of the digestion pattern of the cross-linked ND1 subunit by Asp-N in
the presence or absence of Δlac-acetogenin (2). SMP (1.5 mg of protein/mL) were
cross-linked by 6 nM [125I]DAA in the presence of 3.0 μM (500-fold) of 2. Data shown
are representative of three independent experiments.
Fig. 7. Schematic presentation of amodel for the binding of acetogenin to theND1 subunit.
The present and previous [25] works strongly suggest that site A and site B is the site that
accommodates the bis-THFmotif of natural acetogenins andΔlac-acetogenins, respective-
ly. It is remained to be solved which transmembrane helix, fourth or ﬁfth, accommodates
the γ-lactone ring (see Ref. [16]).
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acetogenin mimic [125I]DAA [25], the cross-linking of the fragment
Asp199-Tyr282 containing the proposed site B was completely blocked
by a 200-fold excess of 2. Taken together, the bindingmanner of the bis-
THF motif of [125I]DANA in the fragment Asp199-Tyr282 may not be
identical to that of Δlac-acetogenin. The apparent suppression of the
cross-linking of ND1 by 2 at high concentrations (Fig. 3)may be due to a
structural change of the protein induced by 2 (i.e. an allosteric effect). In
addition, the extremely efﬁcient suppression of the binding of [125I]
DANA to Asp199-Tyr282 by bullatacin (Fig. 3) may also be due to
indirect effect rather than true competitive behavior, as observed for
[125I]DAA [25].4. Discussion
The ND1 is one of seven mitochondrial-encoded hydrophobic
subunits of the membrane domain of complex I and a mutational hot
spot for mitochondrial diseases like LHON [37] and MELAS [38],
underscoring its physiological role. This subunit has been shown to
play key roles in assembly and functional connection between the
peripheral and membrane domains (Ref. [39] and references therein).
The overall structure of T. thermophilus complex I supports this notion,
though the loop regions of the subunit were not resolved [6]. A series
of photoafﬁnity labeling studies revealed that the ND1 is one of the
subunits (together with the PSST/49 kDa subunits) composing a large
inhibitor binding domain in bovine heart complex I [13,15–17,25].
Acetogenins such as bullatacin and rolliniastatin are among themost
potent inhibitors of bovine heart mitochondrial complex I [12,14]. The
previous studies demonstrated that either of the two pharmacophoric
components (i.e. theγ-lactone and the hydroxylated THF ringmoieties)
synthesized individually showed no or very weak inhibitory effect
[22,40]. Moreover, combined use of the two components exhibited no
synergistic enhancement of the inhibitory activity [22,40]. These
ﬁndings indicate that natural acetogenins elicit the potent inhibition
only when the two pharmacophoric components are directly linked by
the alkyl spacer; probably the two components bind cooperatively to
putative two binding sites. On the other hand, as acetogenins are
tolerant to structural modiﬁcations, a variety of molecular probes led
from acetogenins have been developed for various biochemical and
medicinal researches [reviewed in Ref. 41]. Considering both the very
potent activity and unique structures of acetogenins, closer study on the
actionmechanismof these inhibitorsmay provide valuable insights into
the functional and structural features of complex I.
The present study revealed that the hydroxylated bis-THF motif of
natural acetogenins predominantly resides in the region covering the
fourth transmembrane helix to Arg195. To predict the binding site of themotif in this region, information from structure–activity studies for
numerous acetogenins may be helpful. The studies strongly suggested
that thepolarhydroxylatedbis-THFmotif of these amphiphilic inhibitors
resides at or close to the polar membrane surface with support of the
hydrophobic alkyl spacer and tail [42,43]. Molecular dynamics simula-
tion of natural acetogenins in a fully hydrated phosphatidylcholine
bilayer also indicated that the bis-THF ring is located at the interface of
the lipid bilayer [44,45]. It is therefore most likely that the bis-THFmotif
of acetogenins resides in thematrix-side loop area of the region covering
the fourth transmembranehelix toArg195, namely the “site A”proposed
previously [25]. This idea consists with the previous ﬁnding that the
other pharmacophoric component of acetogenins (i.e. the γ-lactone
ring) binds to the region spanning the fourth to ﬁfth transmembrane
helices (Val144–Glu192) in the ND1 subunit [16]. All together, we
propose a model for the binding of acetogenins to the ND1 subunit, as
illustrated in Fig. 7. The binding of acetogenin to this regionmay disturb
the dynamic interaction between the ND1 and 49 kDa/PSST subunits. In
the model, no speciﬁc conformation of the ﬂexible alkyl spacer is
required to ﬁt into the binding pocket [42,43]. A uniquemechanistic role
of the spacer in anchoring the twopharmacophoric components remains
to be elucidated.
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